JS, Y., & JH, L. (2024). Letter: Risks of proton pump inhibitor treatment in cirrhotic patients-Authors' reply. Alimentary pharmacology & therapeutics, 60(4), 546. https://doi.org/10.1111/apt.18167
Chicago Style (17th ed.) CitationJS, Yoon, and Lee JH. "Letter: Risks of Proton Pump Inhibitor Treatment in Cirrhotic Patients-Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 4 (2024): 546. https://doi.org/10.1111/apt.18167.
MLA (9th ed.) CitationJS, Yoon, and Lee JH. "Letter: Risks of Proton Pump Inhibitor Treatment in Cirrhotic Patients-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 4, 2024, p. 546, https://doi.org/10.1111/apt.18167.
Warning: These citations may not always be 100% accurate.